tradingkey.logo

GeneDx Holdings Corp

WGS
查看詳細走勢圖
84.290USD
+0.210+0.25%
收盤 02/06, 16:00美東報價延遲15分鐘
2.44B總市值
776.72本益比TTM

GeneDx Holdings Corp

84.290
+0.210+0.25%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.25%

5天

-12.44%

1月

-37.93%

6月

-20.37%

今年開始到現在

-35.19%

1年

+35.58%

查看詳細走勢圖

TradingKey GeneDx Holdings Corp股票評分

單位: USD 更新時間: 2026-02-06

操作建議

GeneDx Holdings Corp當前公司基本面數據相對非常健康,最新ESG揭露屬於行業中等水平。增長潛力很大。當前估值合理,在醫療服務供應商行業排名33/75位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為170.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

GeneDx Holdings Corp評分

相關信息

行業排名
33 / 75
全市場排名
174 / 4521
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

GeneDx Holdings Corp亮點

亮點風險
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
業績高增長
公司營業收入穩步增長,連續3年增長30.15%
估值高估
公司最新PE估值776.72,處於3年歷史高位
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉91.00股
活躍度降低
近期活躍度降低,過去20天平均換手率0.10

分析師目標

基於 9 分析師
買入
評級
170.000
目標均價
+102.19%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

GeneDx Holdings Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

GeneDx Holdings Corp簡介

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
公司代碼WGS
公司GeneDx Holdings Corp
CEOStueland (Katherine A)
網址https://sema4.com/
KeyAI